Antibodies/Antigens
| Item Number | Product Name |
|---|---|
| AB144-0401 | UR144 Mab, clone 1 |
| ABBUP-0406 | Buprenorphine mAb, clone 6 |
| ABCOV-0401 | COVID-19 Nucleoprotein mAb |
| ABCOV-0402 | COVID-19 Nucleoprotein mAb |
| ABCOV-0403 | COVID-19 Nucleoprotein mAb |
| ABDEN-0411 | Dengue NS1 mAb |
| ABDEN-0412 | Dengue NS1 mAb |
| ABDEN-0413 | Dengue NS1 mAb |
| ABDEN-0414 | Dengue NS1 mAb |
| ABFEN-0400 | Fentanyl mAb |
| ABIGG-0410 | Human IgG (Fc) mAb |
| ABIGG-0415 | Human IgG (Fc) mAb |
| ABIGG-0432 | Human IgG (Fc) mAb |
| ABIGM-0410 | Human IgM mAb |
| ABIGM-0431 | Human IgM mAb |
| ABINF-0411 | Influenza A mAb |
| ABINF-0412 | Influenza A mAb |
| ABINF-0441 | Influenza B mAb |
| ABINF-0442 | Influenza B mAb |
| ABMAL-0434 | Malaria pLDH mAb, clone 34 |
| ABMAL-0436 | Malaria pLDH mAb, clone 36 |
| ABMAL-0438 | Malaria P. falciparum LDH mAb, clone 38 |
| ABMAL-0447 | Malaria HRPII mAb |
| ABMAL-0448 | Malaria HRPII mAb |
| ABMTD-0402 | Methadone mAb, clone 2 (Saliva) |
| ABOXY-0401 | Oxycodone mAb |
| ABPCP-0405 | Phencyclidine (PCP) mAb |
| ABPCP-0406 | Phencyclidine (PCP) mAb |
| ABSK2-0404 | K2 (Spice) mAb, clone 4 |
| AG144-0301 | UR144 BSA |
| AGBUP-0306 | Buprenorphine BSA |
| AGCOV-0230 | COVID-19 Spike Protein (Source – E.Coli) |
| AGCOV-0231 | COVID-19 Spike Protein (Source – CHO) |
| AGCOV-0232 | COVID-19 Nucleocapsid |
| AGCOV-0233 | COVID-19 Spike Protein (Source – CHO) |
| AGFEN-0301 | Fentanyl BSA |
| AGFEN-0302 | Fentanyl BSA |
| AGHIV-0219 | rHIV gp36 |
| AGHIV-0229 | rHIV gp41 |
| AGHIV-0247 | rHIV gp36/gp41 |
| AGHIV-0248 | rHIV gp36/gp41 |
| AGHIV-0249 | rHIV gp36/gp41 |
| AGPCG-0306 | Phencyclidine (PCP) BTG |
| AGPIN-0301 | AB PINACA BSA |
| AGSK2-0301 | K2 (Spice) BSA |
| AGSPL-0202 | rSyphilis 17 kD |
| AGSPL-0242 | rSyphilis 45 kD |
Gold Conjugates
| Item Number | Product Name |
|---|---|
| CG144-0701 | UR144 mAb CGC |
| CGBUP-0705 | Buprenorphine mAb CGC |
| CGBUP-0706 | Buprenorphine mAb CGC |
| CGCOV-0630 | COVID-19 Spike Protein (Source – E.Coli) CGC |
| CGCOV-0631 | COVID-19 Spike Protein (Source – CHO) CGC |
| CGCOV-0632 | COVID-19 Nucleocapsid CGC |
| CGCOV-0633 | COVID-19 Spike Protein (Source – CHO) CGC |
| CGFEN-0700 | Fentanyl mAb CGC |
| CGCOV-0703 | COVID-19 Nucleoprotein mAb CGC |
| CGBUP-0705 | Buprenorphine mAb CGC |
| CGHIV-0647 | rHIV gp36/gp41 CGC |
| CGHIV-0648 | rHIV gp36/gp41 CGC |
| CGHIV-0649 | rHIV gp36/gp41 CGC |
| CGINF-0712 | Influenza A mAb CGC |
| CGINF-0741 | Influenza B mAb CGC |
| CGMAL-0734 | Malaria pLDH mAb CGC |
| CGMAL-0736 | Malaria pLDH mAb CGC |
| CGMTD-0702 | Methadone mAb CGC |
| CGOXY-0701 | Oxycodone mAb CGC |
| CGSK2-0704 | K2 (Spice) mAb CGC, clone 4 |
| CGSK2-0705 | K2 (Spice) mAb CGC, clone 5 |
| CGSPL-0602 | rSyphilis 17 kD mAb CGC |
| CGSPL-0642 | rSyphilis 45 kD mAb CGC |
About Arista
We believe in formulating material of only the highest caliber, and guarantee the quality of each lot we create. Our mission is to combine innovation with success while continuing to provide competitive prices to our customers. Our technical support team is available anytime to ensure and maintain the excellence of all our reagents and their finished products.
Contact Us
Arista Biologicals
1101 West Hamilton Street,
Allentown, PA 18101 USA
Phone: +1 (484) 223-0309
Fax: +1 (484) 223-0318
info@aristabiologicals.com